Warner Pharmaceutical Factory announced that the closing price of the company's stocks has deviated by 30% for three consecutive trading days, indicating abnormal fluctuations in stock trading. After the company's internal investigation and written inquiries to major shareholders and actual controllers, it was confirmed that there are no significant matters or important information that should have been disclosed but were not. The company's current daily operations are normal, with no major adjustments in the market environment or industry policies. There have been no significant fluctuations in production costs, sales, or internal production and operation order.